Microarray analysis of phosphatase gene expression in human melanoma

Summary Background  Tyrosine phosphate is abnormally elevated in malignant melanoma, and this has been interpreted to reflect the activity of oncogenic protein tyrosine kinases. However, elevation may also arise due to decreased protein tyrosine phosphatase (PTP) expression. Objectives  To survey ph...

Full description

Saved in:
Bibliographic Details
Published in:British journal of dermatology (1951) Vol. 152; no. 5; pp. 925 - 930
Main Authors: McArdle, L., Rafferty, M.M., Satyamoorthy, K., Maelandsmo, G.M., Dervan, P.A., Herlyn, M., Easty, D.J.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Science Ltd 01-05-2005
Blackwell
Oxford University Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background  Tyrosine phosphate is abnormally elevated in malignant melanoma, and this has been interpreted to reflect the activity of oncogenic protein tyrosine kinases. However, elevation may also arise due to decreased protein tyrosine phosphatase (PTP) expression. Objectives  To survey phosphatase gene expression in melanoma cell lines, a benign naevus and normal melanocytes: we searched for downregulation of phosphatase gene expression in malignant cells that may indicate a role as melanoma suppressor genes. Methods  Microarray analysis was used to compare gene expression for 133 phosphatase genes, comprising 39 PTPs, 16 dual‐specificity phosphatases (DSPs), 47 serine/threonine phosphatases and 31 acid/alkaline and lipid‐based phosphatases. Northern blotting analysis was used to study gene expression in human melanoma biopsies. Results  There was decreased expression of four DSP genes (including PTEN); eight receptor PTP genes were downregulated in melanoma, among which were PTP‐KAPPA and PTP‐PI (consistent with our previous data). In addition, PTP‐RF/LAR was downregulated in 13 of 22 metastatic melanomas. Conclusions  The expression of multiple PTP receptors is decreased in melanoma; this may be a mechanism which stimulates autonomous growth in advanced melanoma.
Bibliography:ark:/67375/WNG-W5BSCBDC-V
istex:B5992A29DF51F34DC54B207EE5A269EA49DFF708
ArticleID:BJD6454
Conflicts of interest: None declared.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-0963
1365-2133
DOI:10.1111/j.1365-2133.2005.06454.x